Aruvant

About Aruvant

Aruvant’s mission is to bring hope to patients living with rare diseases by developing life changing and potentially curative gene therapies, with a near-term focus on sickle cell disease. Aruvant is a part of the Roivant family of companies. We have a talented team with extensive experience in the development, manufacturing and commercialization of gene therapy products. We have an active research program with a lead product candidate in development for individuals suffering from sickle cell disease (SCD).

Our lead product candidate, ARU-1801, an investigational lentiviral gene therapy, is currently in a clinical trial as a potential one-time curative treatment for SCD. Preliminary clinical data from the ongoing Phase 1/2 study demonstrated durable efficacy in reducing the negative impacts of SCD. We are preparing for the launch of our pivotal clinical trial in SCD. We continue to look for new people to add to our talented team.

Website	https://aruvant.com/
Employees	1-10 employees View all Aruvant employees
Industry	Biotechnology
Location	151 W 42nd St, New York, NY 10036, US
Founded	None
Keywords	Rare Diseases

Get verified email of Aruvant employees

Aruvant Alternatives

Sterling Addlife India Limited

Biotechnology

Teledyne Photometrics

biotechnology

J. Craig Venter Institute

biotechnology

Neogen EMEA

biotechnology

Cryo-Cell

biotechnology

Crinetics Pharmaceuticals

biotechnology

Louisiana Gene Therapy Research Consortium

Biotechnology

D-PATH Dermatopathogy

Biotechnology

Frequently Asked Questions about Aruvant

Who is the CEO of Aruvant?

Will Chou is the CEO of Aruvant. To contact Will Chou email at [email protected] or [email protected].

Who are the decision makers in Aruvant?

The decision makers in Aruvant are Claire Sutherland, Lee Obrien, Lisa H, etc. Click to Find Aruvant decision makers emails.

How can I contact Aruvant for inquiries about their gene therapy services?

You can reach out to Aruvant by visiting their website and using the 'Contact Us' form. Alternatively, you can email them directly at [email protected] for any inquiries related to their gene therapy services and ongoing clinical trials.

Is there a directory of staff members available at Aruvant?

While Aruvant does not publicly provide a detailed staff directory, you can find key team members and their roles on the 'About Us' section of their website. For specific inquiries, it's best to contact them directly through their official communication channels.

What industries does Aruvant focus on with its gene therapy solutions?

Aruvant specializes in developing gene therapies primarily for the rare disease sector, with a significant focus on sickle cell disease. Their innovative approaches aim to address unmet medical needs in these challenging areas, providing hope for patients and families.

Can I get updates on Aruvant's clinical trials and research initiatives?

Yes, you can stay informed about Aruvant's clinical trials and research initiatives by subscribing to their newsletter on their website. Additionally, they regularly update their news section with the latest developments and milestones in their gene therapy programs.

What is Aruvant's approach to patient engagement and support?

Aruvant is committed to patient engagement by providing resources and support for individuals affected by rare diseases. They encourage patients and families to reach out through their website for information on clinical trials, treatment options, and support services.

How does Aruvant collaborate with other organizations in the rare disease space?

Aruvant actively collaborates with various organizations, including academic institutions and healthcare providers, to advance research and development in gene therapies. These partnerships enhance their capabilities to deliver innovative solutions for patients with rare diseases.